Russell Frank Company’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Russell Frank Company’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,636	Closed	-$45K	–	3155
2014 Q4	$45K	Sell	2,636 -228,441	-99%	-$3.21M	﹤0.01%	2809
2014 Q3	$2.75M	Buy	231,077 +76,115	+49%	+$520K	﹤0.01%	1600
2014 Q2	$817K	Buy	+154,962	New	+$714K	﹤0.01%	2149
2013 Q4	–	Sell	-160,920	Closed	-$682K	–	3373
2013 Q3	$682K	Sell	160,920 -32,516	-17%	-$154K	﹤0.01%	2368
2013 Q2	$890K	Buy	+193,436	New	+$665K	﹤0.01%	2115

Russell Frank Company's AVNR Position: Q1 2015 in Review

Russell Frank Company sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 2,636 shares — an estimated $45K sold.

Russell Frank Company first reported a position in AVNR in Q2 2013 and held it in 5 quarters. The position peaked at $2.75M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Russell Frank Company reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Russell Frank Company sold 2,636 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $45K.
Russell Frank Company first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 5 quarters.
Russell Frank Company's AVANIR PHARMACEUTICALS, INC CL A position peaked at $2.75M in Q3 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Russell Frank Company's 13F filing for Q1 2015, filed 13 May 2015.